Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × OTHER × penpulimab × Clear all

Phase

Phase 2 19 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 50 Cyclophosphamide 35 pembrolizumab 31 Radiotherapy 26 fludarabine 22 Biopsy 22 Nivolumab 20 Metformin 19 Fluorodeoxyglucose F18 18 Bevacizumab 18 Specimen Handling 16 Radiosurgery 13 Cisplatin 12 Temozolomide 11 Carboplatin 11 durvalumab 10 Paclitaxel 10 Dexamethasone 10 X-Rays 9 Immunotherapy, Adoptive 9 Gemcitabine 9 Fluorouracil 9 olaparib 8 gallium Ga 68 dotatate 8 gallium 68 PSMA-11 8 fluciclovine F-18 8 atezolizumab 8 Standard of Care 8 Rituximab 8 Radiation 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06853769 2025-03-03

LARC-nCR01

The First Affiliated Hospital with Nanjing Medical University

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡